A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis
Assessment of Psoriasis Severity in Brazilians Patients With Chronic Plaque-type Psoriasis Attending Outpatient Clinics: a Multicenter, Observational, and Cross-sectional Study (APPISOT)
Sponsor: Janssen Pharmaceutica
This observational or N/A phase trial investigates Plaque and Psoriasis and is currently completed. Janssen Pharmaceutica leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Apr 2017 — Apr 2018 [monthly]
Completed NA
Phase: EARLY_PHASE1 → NA
-
Feb 2017 — Apr 2017 [monthly]
Completed EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed Phase 0
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Janssen Pharmaceutica
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Belo Horizonte, Brazil , Belém, Brazil , Botucatu, Brazil , Brasília, Brazil , Campinas, Brazil , Curitiba, Brazil , Fortaleza, Brazil , Goiânia, Brazil , João Pessoa, Brazil , Porto Alegre, Brazil and 6 more locations